Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Tango Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- +3 vs. Q2 2024
- Shares held
- 101.5M
- +6.90M (+7.3%) vs. Q2 2024
- Total value
- $781.2M
- −$30.1M (−3.7%) vs. Q2 2024
- New holders
- 18
- 39 more added
- Sold out
- 15
- 36 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ArrowMark Colorado Holdings LLC | 708,385 | $5.45M | 0.07% | 00.0% | Unchanged |
| Bessemer Group Inc | 708,384 | $5.46M | 0.01% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 750,000 | $5.78M | 0.06% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,188,349 | $9.15M | 0.61% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,368,262 | $10.5M | 0.00% | +142,710+11.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,540,000 | $11.9M | 0.18% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,294,206 | $17.7M | 0.03% | 00.0% | Unchanged |
| State Street Corp | 2,318,208 | $17.9M | 0.00% | +489,949+26.8% | Added |
| Siren, L.L.C. | 2,603,897 | $20.1M | 1.00% | +2,603,897 | New |
| Balyasny Asset Management LLC | 2,687,196 | $20.7M | 0.05% | +2,410,187+870.1% | Added |
| Citadel Advisors LLC | 2,694,125 | $20.7M | 0.02% | +1,462,368+118.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,712,008 | $20.9M | 2.17% | −180,655−6.2% | Reduced |
| Vanguard Group Inc | 3,645,303 | $28.1M | 0.00% | +350,731+10.6% | Added |
| BlackRock, Inc. | 4,361,335 | $33.6M | 0.00% | +4,361,335 | New |
| Southpoint Capital Advisors LP | 5,000,000 | $38.5M | 0.91% | −276,699−5.2% | Reduced |
| T. Rowe Price Investment Management, Inc. | 5,023,146 | $38.7M | 0.02% | +267,167+5.6% | Added |
| Nextech Invest AG | 5,533,980 | $42.6M | 5.98% | 00.0% | Unchanged |
| Boxer Capital, LLC | 8,198,642 | $63.1M | 3.10% | 00.0% | Unchanged |
| FMR LLC | 9,379,797 | $72.2M | 0.00% | −29,281−0.3% | Reduced |
| EcoR1 Capital, LLC | 13,330,736 | $102.6M | 3.52% | 00.0% | Unchanged |
| TRV GP IV, LLC | 16,859,075 | $129.8M | 80.09% | −2,342,400−12.2% | Reduced |
| Artal Group S.A. | 0 | $0 | 0.00% | −2,519,841−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −447,107−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −348,091−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −150,274−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −38,201−100.0% | Sold out |
| Fishman Jay A Ltd | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,911−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,158−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −10,497−100.0% | Sold out |
| Alaethes Wealth LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −6,944−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −6,281−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −415−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |